BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19076364)

  • 1. Diverse mechanisms and consequences of immunoadoption of neuromediator systems.
    Goetzl EJ; Chan RC; Yadav M
    Ann N Y Acad Sci; 2008 Nov; 1144():56-60. PubMed ID: 19076364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity.
    Yadav M; Goetzl EJ
    Ann N Y Acad Sci; 2008 Nov; 1144():83-9. PubMed ID: 19076367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunomodulation in the intestinal mucosa.
    Ottaway CA
    Gastroenterol Clin North Am; 1991 Sep; 20(3):511-29. PubMed ID: 1717380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes.
    Goetzl EJ
    Regul Pept; 2006 Nov; 137(1-2):75-8. PubMed ID: 16934888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmune mechanisms in health and disease: 1. Health.
    Anisman H; Baines MG; Berczi I; Bernstein CN; Blennerhassett MG; Gorczynski RM; Greenberg AH; Kisil FT; Mathison RD; Nagy E; Nance DM; Perdue MH; Pomerantz DK; Sabbadini ER; Stanisz A; Warrington RJ
    CMAJ; 1996 Oct; 155(7):867-74. PubMed ID: 8837533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide as a healing mediator in Crohn's disease.
    Arranz A; Abad C; Juarranz Y; Leceta J; Martinez C; Gomariz RP
    Neuroimmunomodulation; 2008; 15(1):46-53. PubMed ID: 18667799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
    Chorny A; Gonzalez-Rey E; Varela N; Robledo G; Delgado M
    Regul Pept; 2006 Nov; 137(1-2):67-74. PubMed ID: 16949684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin, immunity and the nervous system.
    Misery L
    Br J Dermatol; 1997 Dec; 137(6):843-50. PubMed ID: 9470898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRH signaling. Molecular specificity for drug targeting in the CNS.
    Refojo D; Holsboer F
    Ann N Y Acad Sci; 2009 Oct; 1179():106-19. PubMed ID: 19906235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
    Zhou C; Yu X; Cai D; Liu C; Li C
    Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychoneuroimmunology--regulation of immunity at the systemic level].
    Boranić M; Sabioncello A; Gabrilovac J
    Lijec Vjesn; 2008; 130(3-4):62-7. PubMed ID: 18592962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A morphological and immunohistochemical investigation of guinea pig skin after the introduction of substance P and VIP.
    Gendek-Kubiak H; Danowski J; Kmieć BL
    Cell Mol Biol Lett; 2003; 8(1):63-7. PubMed ID: 12655358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris.
    Ganceviciene R; Graziene V; Fimmel S; Zouboulis CC
    Br J Dermatol; 2009 Feb; 160(2):345-52. PubMed ID: 19077080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D; Anderson P; Gonzalez-Rey E
    J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone and mast cells in the regulation of mucosal barrier function in the human colon.
    Wallon C; Söderholm JD
    Ann N Y Acad Sci; 2009 May; 1165():206-10. PubMed ID: 19538308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimmunomodulation during exercise: role of catecholamines as 'stress mediator' and/or 'danger signal' for the innate immune response.
    Ortega E; Giraldo E; Hinchado MD; Martín L; García JJ; De la Fuente M
    Neuroimmunomodulation; 2007; 14(3-4):206-12. PubMed ID: 18073516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elaborate interactions between the immune and nervous systems.
    Steinman L
    Nat Immunol; 2004 Jun; 5(6):575-81. PubMed ID: 15164017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmune regulation in immunocompetence, acute illness, and healing.
    Berczi I; Quintanar-Stephano A; Kovacs K
    Ann N Y Acad Sci; 2009 Feb; 1153():220-39. PubMed ID: 19236345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.